King, B O <br/><br/>
Tirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in vitro VAD circulation.  [electronic resource] 

 -  ASAIO journal (American Society for Artificial Internal Organs : 1992)   
 - 282-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1058-2916 
<br/><br/><label>Standard No.: </label>10.1097/00002480-200105000-00025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Platelets--drug effects<br/>Cell Degranulation--drug effects<br/>Complement Activation<br/>Heart-Assist Devices<br/>Humans<br/>In Vitro Techniques<br/>Leukocyte Elastase--metabolism<br/>Leukotriene C4--metabolism<br/>Neutrophils--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Platelet Factor 4--metabolism<br/>Platelet Glycoprotein GPIIb-IIIa Complex--metabolism<br/>Tirofiban<br/>Tyrosine--analogs & derivatives